About Science 37
Science 37 is a company based in Los Angeles (United States) founded in 2014 was acquired by eMed Technologies in January 2024.. Science 37 has raised $106.5 million across 4 funding rounds from investors including Amgen, Novartis and PPD. Science 37 offers products and services including Metasite Platform and Patient Recruitment. Science 37 operates in a competitive market with competitors including Medidata, Verily, IQVIA, TriNetX and Signant Health, among others.
- Headquarter Los Angeles, United States
- Stage Public
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$106.5 M (USD)
in 4 rounds
-
Latest Funding Round
$40 M (USD), Series D
Aug 20, 2020
-
Investors
Amgen
& 11 more
-
Employee Count
Employee Count
-
Acquired by
eMed Technologies
(Jan 29, 2024)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Science 37
Science 37 offers a comprehensive portfolio of products and services, including Metasite Platform and Patient Recruitment. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Enables remote clinical trials for broader patient access and data collection
Facilitates diverse participant enrollment in clinical studies remotely
Unlock access to complete
Funding Insights of Science 37
Science 37 has successfully raised a total of $106.5M across 4 strategic funding rounds. The most recent funding activity was a Series D round of $40 million completed in August 2020. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 4
- Last Round Series D — $40.0M
-
First Round
First Round
(20 Oct 2015)
- Investors Count 11
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Aug, 2020 | Amount | Series D - Science 37 | Valuation | Lux Capital , Redmile Group | |
| Apr, 2017 | Amount | Series C - Science 37 | Valuation | Glynn Capital | |
| Oct, 2016 | Amount | Series B - Science 37 | Valuation | Redmile Group |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Science 37
Science 37 has secured backing from 12 investors, including venture fund and institutional investors. Prominent investors backing the company include Amgen, Novartis and PPD. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Seed and early-stage technology companies are funded by Lux Capital.
|
Founded Year | Domain | Location | |
|
Corporate backed venture capital fund investing in multiple sectors
|
Founded Year | Domain | Location | |
|
Investments are directed toward early and late-stage tech companies.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Science 37
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Science 37
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Science 37 Comparisons
Competitors of Science 37
Science 37 operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Medidata, Verily, IQVIA, TriNetX and Signant Health, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Medidata is recognized as a leading provider of SaaS solutions for clinical research.
|
|
| domain | founded_year | HQ Location |
AI-based solutions for health management are provided.
|
|
| domain | founded_year | HQ Location |
Clinical research and commercialization solutions are provided for healthcare.
|
|
| domain | founded_year | HQ Location |
Clinical trial management software is provided for researchers and professionals.
|
|
| domain | founded_year | HQ Location |
Signant Health is engaged in providing clinical trial technology solutions.
|
|
| domain | founded_year | HQ Location |
Regulatory and ethical review services for clinical research are provided.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Science 37
Frequently Asked Questions about Science 37
When was Science 37 founded?
Science 37 was founded in 2014 and raised its 1st funding round 1 year after it was founded.
Where is Science 37 located?
Science 37 is headquartered in Los Angeles, United States. It is registered at Los Angeles, California, United States.
Who is the current CEO of Science 37?
David Coman is the current CEO of Science 37.
Is Science 37 a funded company?
Science 37 is a funded company, having raised a total of $106.5M across 4 funding rounds to date. The company's 1st funding round was a Series B of $31M, raised on Oct 20, 2015.
What does Science 37 do?
Science 37 was founded in 2014 and is headquartered in Los Angeles, United States. Operations focus on the clinical trials sector, where end-to-end solutions are delivered to support researchers. A mobile platform enables patient participation, while tools like Metasite facilitate site-based data collection, trial management, and communication. Additional features include recruitment systems, patient enrollment processes, and virtualization for study design concepts.
Who are the top competitors of Science 37?
What products or services does Science 37 offer?
Science 37 offers Metasite Platform and Patient Recruitment.
Who are Science 37's investors?
Science 37 has 12 investors. Key investors include Amgen, Novartis, PPD, Mubadala, and eMed Technologies.